Anthem Biosciences (NSE:ANTHEM) Long-Term Debt: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ANTHEM Anthem Biosciences Ltd NSE:ANTHEM
23 GF Score
Price ₹891.65
! 6 Warning Signs
View Full Analysis

What is Anthem Biosciences Long-Term Debt?

Anthem Biosciences NSE:ANTHEM +4.53% 23 Long-Term Debt is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:ANTHEM with a GF Score™ of 23/100. The stock has 6 warning signs investors should review.

Anthem Biosciences's Long-Term Debt for the quarter that ended in Jun. 2026 was ₹0 Mil.

Anthem Biosciences's quarterly Long-Term Debt increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹277 Mil) but then declined from Mar. 2026 (₹277 Mil) to Jun. 2026 (₹0 Mil).

Anthem Biosciences's annual Long-Term Debt declined from Mar. 2024 (₹1,117 Mil) to Mar. 2025 (₹470 Mil) and declined from Mar. 2025 (₹470 Mil) to Mar. 2026 (₹277 Mil).

Anthem Biosciences  (NSE:ANTHEM) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Anthem Biosciences Long-Term Debt Related Terms

Anthem Biosciences Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Anthem Biosciences's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anthem Biosciences Long-Term Debt Chart

Anthem Biosciences Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Long-Term Debt
45.91 961.89 1,116.59 470.28 277.34

Anthem Biosciences Quarterly Data
Mar22 Mar23 Mar24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 373.56 0.00 277.34 0.00
NSE:ANTHEM
23GF Score
Anthem Biosciences Ltd NSE:ANTHEM
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ₹0 Mil mean?
Anthem Biosciences (NSE:ANTHEM) has a Long-Term Debt of ₹0 Mil as of Jun. 2026.
Is Anthem Biosciences' Long-Term Debt too high?
Anthem Biosciences' current Long-Term Debt is ₹0 Mil. Overall, Anthem Biosciences has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Anthem Biosciences' Long-Term Debt compare to VRTX and REGN?
Anthem Biosciences' Long-Term Debt of ₹0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Anthem Biosciences's current Long-Term Debt is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anthem Biosciences stock overvalued right now?
Anthem Biosciences (NSE:ANTHEM) has a current Long-Term Debt of ₹0 Mil. The current Long-Term Debt is ₹0 Mil. Anthem Biosciences' overall GF Score™ is 23/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Anthem Biosciences (NSE:ANTHEM), the current Long-Term Debt is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anthem Biosciences Business Description

Other Exchanges 544449:India
Address No. 49, F1 & F2, Canara Bank Road, Bommasandra Industrial Area, Phase 1, Bommasandra, Bangalore, KA, IND, 560 099
Anthem Biosciences Ltd is an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing. It is one of the few companies in India with integrated New Chemical Entity (NCE) and New Biological Entity (NBE) capabilities across drug discovery, development, and commercial manufacturing. As a one-stop service provider, It serves a range of customers, encompassing innovator-focused emerging biotech and large pharmaceutical companies globally.
23GF Score

Get the complete analysis for NSE:ANTHEM

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹891.65
Price